BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock
PHGE.U
PHGE.U was delisted on the 24th of October, 2024.
2 hedge funds and large institutions have $127 invested in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
60% less funds holding
Funds holding: 5 → 2 (-3)
98% less capital invested
Capital invested by funds: $5.69K → $127 (-$5.56K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$186 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$2.91K |
| 2 |
Walleye Capital
New York
|
-$2.66K |
| 3 |
CS
Clear Street
New York
|
-$75 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$18 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $126 | +$186 | +93 | +2,325% |
|
|
2
Bank of America
Charlotte,
North Carolina
| $1 | -$18 | -9 | -90% |
|
|
3
Walleye Capital
New York
| – | -$2.66K | -1,269 | Closed |
|
|
4
Goldman Sachs
New York
| – | -$2.91K | -1,039 | Closed |
|
|
CS
5
Clear Street
New York
| – | -$75 | -19 | Closed |
|
PHGE.U Hedge Fund Activity: Q3 2024 in Review
2 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) for Q3 2024, worth a combined $127 — down 98% from $5.69K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PHGE.U and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $186. The largest seller was Goldman Sachs, exiting entirely with an estimated $2.91K sold.
- 2 institutional investors held BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) as of Q3 2024, down from 5 in Q2 2024.
- Funds reported $127 of BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock stock for Q3 2024, down 98% quarter-over-quarter.
- 0 funds opened new BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock positions in Q3 2024 and 3 closed out, a net change of -3 holders.
- The largest BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock buyer in Q3 2024 was UBS Group, an estimated $186 added.
- The largest BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock seller in Q3 2024 was Goldman Sachs, an estimated $2.91K sold.
Based on aggregated 13F filings for Q3 2024.